Amy Kruse

General Partner & Chief Investment Officer at Satori Neuro, focusing on mental health, brain health and wellness. Trained neuroscientist with a background at DARPA.

Best podcasts with Amy Kruse

Ranked by the Snipd community

Feb 27, 2025 • 43min

AI, Psychedelics, the Gut-Brain Axis, and New Frontiers in BioTech | From SXSW's Next Stage (Re-release)

In this insightful discussion, Amy Kruse, a neuroscientist and Chief Investment Officer at Satori Neuro, and Matias Serebrinsky, co-founder of PsyMed Ventures, delve into the transformative role of AI and biotechnology in mental health. They explore the hype around psychedelics and emphasize the significance of the gut-brain axis. The duo also highlights the evolution of neurotechnology and the potential for innovative treatments, alongside the challenges of funding health tech startups, particularly focusing on mental wellness and women's health.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.